This RFA is intended to promote productive re-entry of NIH-trained foreign
investigators into their home countries as part of a broader program to
enhance the scientific research infrastructure in developing countries, to
stimulate research on a wide variety of high priority health-related issues
in these countries, and to advance NIH efforts to address health issues of
global import.
The specific goal of this initiative is to provide funding opportunities for
the increasing pool of foreign biomedical and behavioral scientists, clinical
investigators, nurses, and other health professionals with state-of-the-art
knowledge of research methods to advance critical issues in global health
upon their return to their home countries. After their term of research
training, developing country participants supported by this RFA are expected
to continue independent and productive scientific careers, including expert
training and consultation and/or research of biomedical issues within their
home institutions.
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Expiration Date: Wednesday, February 19, 2003 NOFO Number: RFA-TW-03-006 Release Date: Monday, November 4, 2002 Notice Type: RFA
Expiration Date: Tuesday, February 25, 2003 NOFO Number: RFA-AR-03-002 Release Date: Thursday, October 31, 2002 Notice Type: RFA
The National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS), the National Institute of Neurological Disorders and Stroke (NINDS)
and the National Institute of Child Health and Human Development (NICHD) seek
developmental planning grant applications for the establishment of an
infrastructure for eventual Muscular Dystrophy Cooperative Research Centers
(MDCRCs). This initiative supports the planning of new or expansion of
existing resources for future competitive MDCRCs. These planning grants will
enable applicants to effectively organize and integrate multidisciplinary
research capacities and core resources to enhance collaborations of basic,
clinical, and behavioral science in muscular dystrophy research and to
promote cross-disciplinary research training.
Participation in this RFA will not itself be a factor in the review of any
Center application. Investigators may respond to current (e.g., RFA AR03-
001) or future solicitations for center grant applications without first
having participated in this developmental planning initiative.
Investigators interested in applying for support of muscular dystrophy
research using mechanisms other than centers or this developmental planning
initiative should see NIH PAS01-041, "Therapeutic and Pathogenic Approaches
for the Muscular Dystrophies"
(http://www.niams.nih.gov/rtac/funding/grants/pa/pas_01_041.pdf).
Expiration Date: Tuesday, February 15, 2005 NOFO Number: PAR-03-007 Release Date: Thursday, October 10, 2002 Notice Type: PAR
This PA solicits applications to develop new genetic-based methods and
technologies for the purpose of mapping functional neuronal circuits and
synaptic changes in the mammalian nervous system. Emerging genetic and
transgenic technologies can be used to single out functionally related cells
or neuronal populations for analysis or intervention. This PA would support
the development of genetic-based tools to map neuronal interconnectivity, to
monitor functional changes, or to drive functional changes within neuronal
circuits as the first step in an effort by the NIH to create integrated
genomic and functional connectivity maps of the mammalian nervous system.
Other corollary efforts needed to generate integrated connectivity maps such
as improved neuroinformatics and the development of a large consortia of
investigators, however, are outside the scope of this program announcement.
Wide distribution to the scientific community of the methods and resulting
resources developed under this program is essential for the eventual goal of
creating large-scale functional connectivity maps of the mammalian nervous
system. The unrestricted distribution of methods and resources developed
under this program will also facilitate the rapid transfer of technology for
the development of diagnostic tools and treatment interventions for brain
disease.
Expiration Date: Wednesday, November 2, 2005 NOFO Number: PAR-03-004 Release Date: Monday, October 7, 2002 Notice Type: PAR
In response to continuing research progress and opportunity, and in
recognition of continuing Congressional interest to intensify and to
expand basic and clinical research in Parkinson's disease, The National
Institute of Neurological Disorders and Stroke (NINDS) and the National
Institute of Environmental Health Sciences (NIEHS) invite qualified
investigators to submit grant applications for the establishment of
Morris K. Udall Parkinson's Disease Research Centers of Excellence.
The purpose of this Program Announcement (PA) is to encourage
additional research opportunities and discoveries that will lead to
improved diagnosis and treatment of patients with Parkinson's Disease
and related neurodegenerative disorders, based on a better
understanding of the fundamental cause(s) of the disease. It is
expected that these Centers will form a consortium of investigators
that will foster an environment that will enhance research
effectiveness in a multi-disciplinary setting, utilizing specialized
methods relevant to the study of these disorders. There were two
previous requests
(http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-98-001.html and
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-99-004.html.
Expiration Date: Tuesday, February 25, 2003 NOFO Number: RFA-AR-03-001 Release Date: Monday, September 23, 2002 Notice Type: RFA
The purpose of this Request for Applications (RFA) is to establish Muscular
Dystrophy Cooperative Research Centers (MDCRCs), in order to increase basic
and clinical research on all forms of muscular dystrophy. The National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the
National Institute of Neurological Disorders and Stroke (NINDS), and the
National Institute of Child Health and Human Development (NICHD) invite
applications for MDCRCs that promote side-by-side basic, translational, and
clinical research, provide resources that can be used by the national muscle
biology and neuromuscular research communities, and provide training and
advice about muscle diseases for researchers and physicians who provide
initial diagnosis and treatment, including rehabilitation, care for cognitive
and behavioral concerns, and therapy for other system complications. Taken
together, the centers will constitute a cohesive program, the MDCRC Program,
operating under guidelines for NIH cooperative agreements.
Expiration Date: Thursday, February 2, 2006 NOFO Number: PA-02-165 Release Date: Tuesday, September 10, 2002 Notice Type: PA
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
the National Institute of Neurological Disorders and Stroke (NINDS), the
National Eye Institute (NEI), the National Institute of Nursing Research
(NINR), and the National Heart, Lung, and Blood Institute (NHLBI) seek
research to understand racial/ethnic disparities in the development of the
microvascular (nephropathy, retinopathy, and neuropathy), and macrovascular
(cardiovascular disease and stroke) complications of diabetes.
Expiration Date: Wednesday, August 31, 2005 NOFO Number: PA-02-156 Release Date: Tuesday, August 27, 2002 Notice Type: PA
Dystonia is defined clinically as involuntary, often sustained, co-
contraction of agonist and antagonist muscles causing abnormal and often
painful postures or movements. It is generally believed to be centrally
mediated. Dystonia occurs due to many different etiologies. Although the
prevalence and disease burden of this group of disorders is not well known,
it is estimated by some sources that this debilitating movement disorder
affects over 500,000 individuals in the USA. Some forms of dystonia are
associated with specific genetic and/or environmental risk factors, but the
underlying pathophysiological pathways remain elusive. The purpose of this
program announcement is to solicit applications for new studies on the
underlying causes of human dystonia, secondary consequences of these movement
disorders, and potential therapeutic strategies for treating these
conditions.
Expiration Date: Tuesday, June 1, 2004 NOFO Number: PA-02-147 Release Date: Friday, August 9, 2002 Notice Type: PA
The purpose of this program announcement (PA) is to encourage the submission
of applications for research to enhance animal stem cells as model biological
systems. Research to isolate, characterize and identify totipotent and
multipotent stem cells from nonhuman biomedical research animal models, as
well as to generate reagents and techniques to characterize and separate
those stem cells from other cell types is encouraged. Innovative approaches
to the problems of making multipotent stem cells available from a variety of
nonhuman sources, and to creating reagents that will identify those stem
cells across species and allow for separation of multipotent stem cells from
differentiated cell types, will be stressed. Studies involving human
subjects are not allowed under this PA. This PA supersedes PA-01-076 issued
earlier by the NCRR.
Expiration Date: Saturday, November 20, 2004 NOFO Number: PAR-02-142 Release Date: Friday, August 2, 2002 Notice Type: PAR
This Program Announcement (PA) is to encourage investigator-initiated
applications for research designed to exploit the power of mutagenesis
screening in zebrafish in order to detect and characterize genes, pathways,
and phenotypes of interest in development and aging, organ formation,
behavior, and disease processes. Applications that propose to advance the
technologies associated with such phenotyping also are welcome. A secondary
goal of this PA is to ensure that tools developed under this initiative are
widely available to the research community. This PA is a continuation of the
program initiated by RFA HD-00-004, "Mutagenesis Screens/Phenotyping Tools for
Zebrafish" (http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-00-004.html),
and incorporates an earlier PA, "Development of Zebrafish Mutagenesis and
Screening Tools" (http://grants.nih.gov/grants/guide/pa-files/PA-01-070.html).
This effort stems from an NIH initiative with participation of the Institutes
and Centers listed above, working though the Trans-NIH Zebrafish Coordinating
Committee (TZCC; http://www.nih.gov/science/models/zebrafish/)
under the co-chairmanship of NICHD and NIDDK. Since its formation in 1997,
the committee has played an active role as an advocate for the zebrafish as an
important model for development and disease research.
Expiration Date: Sunday, July 31, 2005 NOFO Number: PAR-02-140 Release Date: Friday, July 26, 2002 Notice Type: PAR
Recent discoveries across a broad range of research areas in the neurosciences
offer promising opportunities for improved therapies for neurological disorders.
As part of its mission to reduce the burden of neurological disease, NINDS is
committed to encouraging the "translation" of these basic discoveries into new
treatments. The goal of this PA is to announce a career development opportunity
for new investigators to build a program of translational research in
neurological disorders under the guidance of an experienced mentor.